Historical snapshot from Q3 2024.View current holdings →
In Q3 2024, Deerfield Management held 267 positions worth $5.2B. They initiated 136 new positions and exited 334. Their largest holding was NUVL ($2.0B). Portfolio value grew +20.5% versus the prior quarter.
Portfolio Value (13F)
$5.2B
Holdings
267
Top 10 Concentration
66.8%
QoQ Change
+20.5%
Turnover
4.7%
Sector Breakdown
Biotechnology90%(229)
Other Healthcare10%(38)
Q3 2024 Holdings (267)
| # | Ticker | Company | Change | Value | % of Portfolio | SI % Float ? |
|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc. | $2.0B | 39.46% | 6.2% | |
| 2 | VTRS | Viatris Inc. | Increased | $278.6M | 5.37% | 3.7% |
| 3 | OSCR | Oscar Health, Inc. | Increased | $166.5M | 3.21% | 6.5% |
| 4 | SPRY | ARS Pharmaceuticals, Inc. | $160.6M | 3.10% | 30.7% | |
| 5 | NBIX | Neurocrine Biosciences Inc. | Increased | $151.7M | 2.93% | 7.5% |
| 6 | LRMR | Larimar Therapeutics, Inc. | $139.1M | 2.68% | 22.9% | |
| 7 | WAYOther Healthcare | Waystar Holding Corp. | $138.1M | 2.66% | 9.6% | |
| 8 | RVMD | Revolution Medicines Inc. | Decreased | $132.1M | 2.55% | 5.9% |
| 9 | ALHC | Alignment Healthcare, Inc. | Decreased | $128.3M | 2.48% | 11.7% |
| 10 | CPRX | Catalyst Pharmaceuticals Inc. | Decreased | $123.8M | 2.39% | 8.3% |
| 11 | AHCO | AdaptHealth Corp. | Decreased | $109.1M | 2.10% | 9.6% |
| 12 | KURA | Kura Oncology, Inc. | $105.7M | 2.04% | 16.6% | |
| 13 | IDYA | IDEAYA Biosciences Inc. | Increased | $82.2M | 1.59% | 11.1% |
| 14 | BCRX | Biocryst Pharmaceuticals Inc. | $61.8M | 1.19% | 10.8% | |
| 15 | SGRYOther Healthcare | Surgery Partners, Inc. | Decreased | $57.4M | 1.11% | 21.7% |
| 16 | CVSOther Healthcare | Cvs Health Corp. | Decreased | $55.0M | 1.06% | 1.3% |
| 17 | CGEM | Cullinan Therapeutics, Inc. | Held | $54.9M | 1.06% | 16.5% |
| 18 | IRON | Disc Medicine Inc. | $50.3M | 0.97% | 22.1% | |
| 19 | INDV | Indivior Pharmaceuticals, Inc. | New | $49.7M | 0.96% | 10.5% |
| 20 | EWTX | Edgewise Therapeutics, Inc. | Decreased | $47.5M | 0.92% | 14.6% |
| 21 | BCAX | Bicara Therapeutics Inc. | New | $45.7M | 0.88% | 22.5% |
| 22 | CNMDOther Healthcare | Conmed Corp. | Decreased | $44.2M | 0.85% | 7.8% |
| 23 | GLPGF | Galapagos NV | $40.6M | 0.78% | — | |
| 24 | COGT | Cogent Biosciences Inc. | $40.4M | 0.78% | 11.3% | |
| 25 | ALNY | Alnylam Pharmaceuticals Inc. | Increased | $39.9M | 0.77% | 7.7% |
| 26 | EHABOther Healthcare | Enhabit, Inc. | $39.5M | 0.76% | 2.4% | |
| 27 | EMBCOther Healthcare | Embecta Corp. | Held | $38.5M | 0.74% | 12.4% |
| 28 | PHVS | Pharvaris N.V. | Increased | $37.6M | 0.73% | 3.5% |
| 29 | GPCR | Structure Therapeutics Inc. | $37.1M | 0.72% | 14.5% | |
| 30 | DAWN | Day One Biopharmaceuticals Inc. | Decreased | $36.5M | 0.70% | 7.5% |
| 31 | TXG | 10x Genomics Inc. | Increased | $34.1M | 0.66% | 17.3% |
| 32 | CGON | CG Oncology, Inc. | Increased | $32.1M | 0.62% | 12.0% |
| 33 | DCGOOther Healthcare | DocGo Inc. | Increased | $30.1M | 0.58% | 2.1% |
| 34 | FHTX | Foghorn Therapeutics Inc. | Increased | $28.2M | 0.54% | 6.6% |
| 35 | MREO | Mereo BioPharma Group plc | $27.6M | 0.53% | 2.1% | |
| 36 | SVRA | Savara Inc. | New | $27.4M | 0.53% | 24.8% |
| 37 | INMDOther Healthcare | InMode Ltd. | Increased | $26.8M | 0.52% | 4.4% |
| 38 | PACSOther Healthcare | PACS Group, Inc. | $26.5M | 0.51% | 8.6% | |
| 39 | ZBIO | Zenas BioPharma, Inc. | New | $26.4M | 0.51% | 26.9% |
| 40 | LNTH | Lantheus Holdings Inc. | $26.4M | 0.51% | 6.8% | |
| 41 | PCVX | Vaxcyte Inc. | Increased | $25.7M | 0.50% | 11.7% |
| 42 | PODDOther Healthcare | Insulet Corp. | Decreased | $25.5M | 0.49% | 8.7% |
| 43 | BNTX | BioNTech SE | Decreased | $20.7M | 0.40% | 3.7% |
| 44 | DYN | Dyne Therapeutics Inc. | Increased | $15.6M | 0.30% | 17.8% |
| 45 | NAMSW | NewAmsterdam Pharma Co N.V. | Increased | $15.6M | 0.30% | — |
| 46 | RXRX | Recursion Pharmaceuticals Inc. | New | $15.3M | 0.29% | 30.9% |
| 47 | ACCDOther Healthcare | Accolade Inc. | $13.4M | 0.26% | — | |
| 48 | AUTL | Autolus Therapeutics plc | $13.2M | 0.25% | 4.9% | |
| 49 | FATE | Fate Therapeutics Inc. | $12.4M | 0.24% | 10.1% | |
| 50 | PHR | Phreesia, Inc. | Increased | $12.4M | 0.24% | 6.0% |
| 51 | TNGX | Tango Therapeutics Inc. | $11.9M | 0.23% | 26.7% | |
| 52 | NKTX | Nkarta, Inc. | Decreased | $9.7M | 0.19% | 6.4% |
| 53 | PRLD | Prelude Therapeutics Inc. | Decreased | $7.8M | 0.15% | 18.1% |
| 54 | ALEC | Alector Inc. | Decreased | $4.9M | 0.09% | 5.8% |
| 55 | KYTX | Kyverna Therapeutics, Inc. | Decreased | $4.5M | 0.09% | 18.3% |
| 56 | CALC | CalciMedica, Inc. | $4.4M | 0.09% | 2.3% | |
| 57 | INSM | Insmed Incorporated | Increased | $3.9M | 0.07% | 7.1% |
| 58 | PRME | Prime Medicine, Inc. | $3.5M | 0.07% | 22.6% | |
| 59 | ANNX | Annexon Biosciences Inc. | $3.5M | 0.07% | 17.9% | |
| 60 | NVDA | Nvidia Corp. | Increased | $2.0M | 0.04% | 1.3% |
| 61 | CENTA | Central Garden & Pet CO | New | $2.0M | 0.04% | 4.2% |
| 62 | PHGE | BiomX Inc. | Decreased | $1.8M | 0.04% | 2.3% |
| 63 | UTI | Universal Technical Institute Inc. | Decreased | $1.7M | 0.03% | 13.9% |
| 64 | WSO-B | Watsco Inc. | New | $1.7M | 0.03% | 0.0% |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | Increased | $1.7M | 0.03% | 7.6% |
| 66 | UA | Under Armour, Inc. | New | $1.6M | 0.03% | — |
| 67 | FHN-PH | First Horizon Corp. | Increased | $1.6M | 0.03% | — |
| 68 | AXP | American Express CO | Increased | $1.5M | 0.03% | 2.1% |
| 69 | PRVAOther Healthcare | Privia Health Group, Inc. | New | $1.5M | 0.03% | 6.7% |
| 70 | BYRN | Byrna Technologies Inc. | New | $1.4M | 0.03% | 6.7% |
| 71 | MMS | Maximus, Inc. | Increased | $1.4M | 0.03% | 11.6% |
| 72 | JOE | ST Joe Co | New | $1.4M | 0.03% | 4.1% |
| 73 | WEAV | Weave Communications, Inc. | Increased | $1.4M | 0.03% | 7.5% |
| 74 | EXAS | Exact Sciences Corporation | New | $1.4M | 0.03% | 3.9% |
| 75 | STRO | Sutro Biopharma, Inc. | Increased | $1.2M | 0.02% | 11.2% |
| 76 | COLL | Collegium Pharmaceutical, Inc. | Increased | $1.2M | 0.02% | 20.2% |
| 77 | NVAX | Novavax Inc. | New | $1.2M | 0.02% | 28.1% |
| 78 | LTH | Life Time Group Holdings, Inc. | Increased | $1.2M | 0.02% | 8.3% |
| 79 | MNKD | MannKind Corporation | Decreased | $1.1M | 0.02% | 8.2% |
| 80 | AMPL | Amplitude, Inc. | New | $1.1M | 0.02% | 8.3% |
| 81 | LECO | Lincoln Electric Holdings Inc. | New | $1.1M | 0.02% | 2.5% |
| 82 | TOIIWOther Healthcare | Oncology Institute, Inc. | $1.1M | 0.02% | — | |
| 83 | BSXOther Healthcare | Boston Scientific Corp. | New | $1.1M | 0.02% | 2.9% |
| 84 | DT | Dynatrace, Inc. | New | $1.1M | 0.02% | 5.7% |
| 85 | TT | Trane Technologies plc | New | $1.1M | 0.02% | 1.7% |
| 86 | HNRG | Hallador Energy CO | Increased | $1.1M | 0.02% | 10.4% |
| 87 | TWST | Twist Bioscience Corporation | Increased | $1.1M | 0.02% | 20.1% |
| 88 | CGABL | Carlyle Group Inc. | New | $1.1M | 0.02% | — |
| 89 | HCKT | Hackett Group, Inc. | New | $1.0M | 0.02% | 5.2% |
| 90 | PLAB | Photronics Inc. | New | $1.0M | 0.02% | 9.9% |
| 91 | VEEV | Veeva Systems Inc. | Increased | $1.0M | 0.02% | 3.3% |
| 92 | ABSI | Absci Corp. | Increased | $1.0M | 0.02% | 26.6% |
| 93 | UPBD | Upbound Group, Inc. | New | $992K | 0.02% | 18.2% |
| 94 | NHC | National Healthcare Corp. | Increased | $983K | 0.02% | 6.4% |
| 95 | WAFDP | Wafd Inc. | New | $976K | 0.02% | — |
| 96 | NTNX | Nutanix, Inc. | Increased | $973K | 0.02% | 6.0% |
| 97 | XELLL | Xcel Energy Inc. | New | $965K | 0.02% | — |
| 98 | HQYOther Healthcare | Healthequity, Inc. | Increased | $964K | 0.02% | 9.6% |
| 99 | CDNA | CareDx Inc. | New | $964K | 0.02% | 13.0% |
| 100 | MRK | Merck & Co., Inc. | Increased | $963K | 0.02% | 1.1% |
| 101 | BANC-PF | Banc OF California, Inc. | New | $960K | 0.02% | — |
| 102 | ZS | Zscaler, Inc. | New | $957K | 0.02% | 5.4% |
| 103 | HLIO | Helios Technologies, Inc. | New | $954K | 0.02% | 2.8% |
| 104 | GRC | Gorman Rupp CO | New | $945K | 0.02% | 2.8% |
| 105 | COF-PN | Capital One Financial Corp. | New | $942K | 0.02% | — |
| 106 | ADMA | ADMA Biologics Inc. | Decreased | $940K | 0.02% | 11.3% |
| 107 | CRS | Carpenter Technology Corp. | New | $936K | 0.02% | 3.0% |
| 108 | ALG | Alamo Group Inc. | New | $927K | 0.02% | 5.0% |
| 109 | TECH | Bio-Techne Corporation | Decreased | $922K | 0.02% | 4.7% |
| 110 | TRDA | Entrada Therapeutics, Inc. | New | $916K | 0.02% | 11.9% |
| 111 | DBRG-PJ | DigitalBridge Group, Inc. | New | $916K | 0.02% | 1.3% |
| 112 | MU | Micron Technology Inc. | Increased | $895K | 0.02% | 2.3% |
| 113 | MRCY | Mercury Systems Inc. | Increased | $882K | 0.02% | 9.5% |
| 114 | VLTO | Veralto Corp. | New | $874K | 0.02% | 3.0% |
| 115 | MAX | MediaAlpha, Inc. | Increased | $871K | 0.02% | 9.4% |
| 116 | SWK | Stanley Black & Decker, Inc. | New | $868K | 0.02% | 5.5% |
| 117 | CAHOther Healthcare | Cardinal Health Inc. | Increased | $867K | 0.02% | 3.7% |
| 118 | SYNA | Synaptics Inc. | New | $861K | 0.02% | 11.6% |
| 119 | NBBK | NB Bancorp, Inc. | New | $861K | 0.02% | 4.3% |
| 120 | KBR | Kbr, Inc. | New | $858K | 0.02% | 9.8% |
| 121 | DLTR | Dollar Tree, Inc. | Increased | $857K | 0.02% | 4.8% |
| 122 | ESAB | Esab Corp. | Increased | $856K | 0.02% | 10.3% |
| 123 | NVRI | Enviri Corp. | New | $852K | 0.02% | — |
| 124 | WDFC | WD 40 CO | New | $834K | 0.02% | 5.7% |
| 125 | HTLD | Heartland Express Inc. | New | $833K | 0.02% | 7.9% |
| 126 | VREXOther Healthcare | Varex Imaging Corp. | Increased | $830K | 0.02% | 4.4% |
| 127 | LABOther Healthcare | Standard Biotools Inc. | Increased | $804K | 0.02% | 1.1% |
| 128 | ORIC | ORIC Pharmaceuticals Inc. | New | $804K | 0.02% | 15.9% |
| 129 | PGNYOther Healthcare | Progyny Inc. | Increased | $797K | 0.02% | 9.4% |
| 130 | UBER | Uber Technologies, Inc. | Decreased | $787K | 0.02% | 2.5% |
| 131 | COROther Healthcare | Cencora, Inc. | New | $784K | 0.02% | 2.3% |
| 132 | MRVL | Marvell Technology, Inc. | Increased | $782K | 0.02% | 3.2% |
| 133 | ESE | Esco Technologies Inc. | New | $780K | 0.02% | 3.3% |
| 134 | AQST | Aquestive Therapeutics, Inc. | Increased | $773K | 0.01% | 24.0% |
| 135 | KRYS | Krystal Biotech Inc. | Increased | $758K | 0.01% | 19.2% |
| 136 | PEBO | Peoples Bancorp Inc. | New | $752K | 0.01% | 5.2% |
| 137 | BVSOther Healthcare | Bioventus Inc. | New | $752K | 0.01% | 6.7% |
| 138 | SLMBP | SLM Corp. | New | $750K | 0.01% | — |
| 139 | DAR | Darling Ingredients Inc. | New | $746K | 0.01% | 3.5% |
| 140 | EVTC | Evertec, Inc. | New | $744K | 0.01% | 6.3% |
| 141 | YUMC | Yum China Holdings, Inc. | New | $739K | 0.01% | 1.8% |
| 142 | PM | Philip Morris International Inc. | New | $738K | 0.01% | 1.1% |
| 143 | TSLA | Tesla, Inc. | New | $730K | 0.01% | 2.0% |
| 144 | RSMDF | Resmed Inc. | Decreased | $716K | 0.01% | — |
| 145 | PLDGP | Prologis, Inc. | New | $709K | 0.01% | — |
| 146 | USAC | USA Compression Partners, LP | New | $703K | 0.01% | 1.8% |
| 147 | HZNP | Horizon Therapeutics Public Ltd. | New | $689K | 0.01% | — |
| 148 | EW | Edwards Lifesciences Corp. | New | $682K | 0.01% | 1.9% |
| 149 | BRBR | Bellring Brands, Inc. | Increased | $682K | 0.01% | 12.1% |
| 150 | CYTK | Cytokinetics Incorporated | Increased | $680K | 0.01% | 21.2% |
| 151 | BIIB | Biogen Inc. | Increased | $679K | 0.01% | 4.5% |
| 152 | TRMB | Trimble Inc. | New | $664K | 0.01% | 4.9% |
| 153 | PRCTOther Healthcare | PROCEPT BioRobotics Corp. | Decreased | $656K | 0.01% | 13.3% |
| 154 | BMRN | BioMarin Pharmaceutical Inc. | Decreased | $651K | 0.01% | 6.0% |
| 155 | ELAN | Elanco Animal Health Inc. | New | $634K | 0.01% | 11.9% |
| 156 | MA | Mastercard Inc. | New | $632K | 0.01% | 0.7% |
| 157 | EBS | Emergent BioSolutions Inc. | New | $632K | 0.01% | 18.4% |
| 158 | EVER | EverQuote, Inc. | New | $627K | 0.01% | 29.6% |
| 159 | HROW | Harrow, Inc. | Decreased | $623K | 0.01% | 23.0% |
| 160 | ZYME | Zymeworks Inc. | New | $622K | 0.01% | 11.2% |
| 161 | VITL | Vital Farms, Inc. | Increased | $610K | 0.01% | 29.1% |
| 162 | BROS | Dutch Bros Inc. | New | $600K | 0.01% | 50.5% |
| 163 | AVXL | Anavex Life Sciences Corp. | Increased | $599K | 0.01% | 14.9% |
| 164 | ACCO | Acco Brands Corp. | New | $568K | 0.01% | 7.1% |
| 165 | REI | Ring Energy, Inc. | New | $567K | 0.01% | 3.7% |
| 166 | RDN | Radian Group Inc. | New | $560K | 0.01% | 6.1% |
| 167 | SBUX | Starbucks Corp. | New | $552K | 0.01% | 4.1% |
| 168 | DRUG | Bright Minds Biosciences Inc. | Increased | $552K | 0.01% | 11.6% |
| 169 | MDXG | MiMedx Group Inc. | New | $547K | 0.01% | 8.1% |
| 170 | PAYC | Paycom Software, Inc. | New | $521K | 0.01% | 6.7% |
| 171 | SNBR | Sleep Number Corp. | New | $518K | 0.01% | 30.6% |
| 172 | ARWR | Arrowhead Pharmaceuticals Inc. | Increased | $512K | 0.01% | 10.6% |
| 173 | GHM | Graham Corp. | New | $507K | 0.01% | 9.3% |
| 174 | PLMR | Palomar Holdings, Inc. | New | $501K | 0.01% | 3.4% |
| 175 | DXCMOther Healthcare | DexCom Inc. | Increased | $495K | 0.01% | 4.3% |
| 176 | LRN | Stride, Inc. | New | $490K | 0.01% | 27.5% |
| 177 | KIDSOther Healthcare | Orthopediatrics Corp. | Increased | $485K | 0.01% | 5.2% |
| 178 | CSTL | Castle Biosciences Inc. | Decreased | $483K | 0.01% | 6.7% |
| 179 | TAP-A | Molson Coors Beverage CO | New | $478K | 0.01% | 0.1% |
| 180 | PRLB | Proto Labs Inc. | Decreased | $476K | 0.01% | 4.3% |
| 181 | BA-PA | Boeing CO | Increased | $475K | 0.01% | — |
| 182 | FLGT | Fulgent Genetics Inc. | Increased | $471K | 0.01% | 13.1% |
| 183 | RMR | Rmr Group Inc. | New | $461K | 0.01% | 9.3% |
| 184 | TNET | Trinet Group, Inc. | New | $460K | 0.01% | 6.8% |
| 185 | LFSTOther Healthcare | LifeStance Health Group, Inc. | New | $454K | 0.01% | 8.5% |
| 186 | INO | Inovio Pharmaceuticals, Inc. | New | $442K | 0.01% | 22.3% |
| 187 | CIOther Healthcare | Cigna Group | Increased | $437K | 0.01% | 2.9% |
| 188 | CRLOther Healthcare | Charles River Laboratories International Inc. | New | $434K | 0.01% | 7.0% |
| 189 | CXM | Sprinklr, Inc. | New | $431K | 0.01% | 10.1% |
| 190 | NNN | Nnn Reit, Inc. | New | $431K | 0.01% | 5.2% |
| 191 | TKO | TKO Group Holdings, Inc. | New | $430K | 0.01% | 11.3% |
| 192 | USFD | US Foods Holding Corp. | New | $421K | 0.01% | 7.2% |
| 193 | RUN | Sunrun Inc. | Increased | $421K | 0.01% | 35.2% |
| 194 | VCYT | Veracyte, Inc. | Increased | $410K | 0.01% | 15.0% |
| 195 | WCN | Waste Connections, Inc. | Increased | $406K | 0.01% | 1.8% |
| 196 | DVAOther Healthcare | Davita Inc. | Increased | $405K | 0.01% | 15.9% |
| 197 | GSCE | Goldman Sachs Group Inc. | New | $400K | 0.01% | — |
| 198 | NVSTOther Healthcare | Envista Holdings Corp. | New | $399K | 0.01% | 8.4% |
| 199 | OLMA | Olema Pharmaceuticals, Inc. | Increased | $398K | 0.01% | 20.4% |
| 200 | FF | FutureFuel Corp. | New | $396K | 0.01% | 5.0% |
| 201 | CGBD | Carlyle Secured Lending, Inc. | New | $390K | 0.01% | 5.0% |
| 202 | GTLS | Chart Industries Inc. | Decreased | $389K | 0.01% | 10.9% |
| 203 | FNF | Fidelity National Financial, Inc. | New | $386K | 0.01% | 5.2% |
| 204 | MSFT | Microsoft Corp. | New | $381K | 0.01% | 0.8% |
| 205 | SFBS | ServisFirst Bancshares, Inc. | New | $376K | 0.01% | 7.0% |
| 206 | CMPS | COMPASS Pathways plc | New | $366K | 0.01% | 12.5% |
| 207 | IRMD | Iradimed Corp. | New | $359K | 0.01% | 7.9% |
| 208 | INGR | Ingredion Inc. | New | $357K | 0.01% | 8.6% |
| 209 | RMBS | Rambus Inc. | New | $347K | 0.01% | 6.0% |
| 210 | TNC | Tennant CO | New | $342K | 0.01% | 11.6% |
| 211 | SLNO | Soleno Therapeutics Inc. | New | $342K | 0.01% | 17.9% |
| 212 | TRUP | Trupanion, Inc. | New | $339K | 0.01% | 10.7% |
| 213 | EHCOther Healthcare | Encompass Health Corp. | Decreased | $332K | 0.01% | 4.0% |
| 214 | ALV | Autoliv Inc. | New | $331K | 0.01% | 7.8% |
| 215 | MED | Medifast Inc. | New | $330K | 0.01% | 9.8% |
| 216 | ZTS | Zoetis Inc. | Decreased | $329K | 0.01% | 5.0% |
| 217 | DHOther Healthcare | Definitive Healthcare Corp. | New | $328K | 0.01% | 3.7% |
| 218 | HOPE | Hope Bancorp Inc. | New | $326K | 0.01% | 7.8% |
| 219 | CRVL | Corvel Corp. | New | $322K | 0.01% | 10.6% |
| 220 | AMD | Advanced Micro Devices Inc. | New | $317K | 0.01% | 2.4% |
| 221 | TLRY | Tilray Brands, Inc. | New | $311K | 0.01% | 12.8% |
| 222 | CNDT | Conduent Inc. | New | $304K | 0.01% | 3.2% |
| 223 | CUBE | CubeSmart | New | $299K | 0.01% | 5.5% |
| 224 | ABG | Asbury Automotive Group Inc. | New | $296K | 0.01% | 12.9% |
| 225 | AFL | Aflac Inc. | New | $296K | 0.01% | 3.0% |
| 226 | AVGO | Broadcom Inc. | Increased | $289K | 0.01% | 1.2% |
| 227 | CEVA | Ceva Inc. | New | $288K | 0.01% | 11.4% |
| 228 | UTHR | United Therapeutics Corporation | New | $285K | 0.01% | 9.8% |
| 229 | IMO | Imperial Oil Ltd. | New | $284K | 0.01% | 19.0% |
| 230 | WWD | Woodward, Inc. | Held | $280K | 0.01% | 2.1% |
| 231 | UWMC | UWM Holdings Corp. | New | $277K | 0.01% | 29.1% |
| 232 | RTX | RTX Corp. | New | $277K | 0.01% | 1.0% |
| 233 | ENSGOther Healthcare | The Ensign Group Inc. | New | $277K | 0.01% | 3.0% |
| 234 | QS | QuantumScape Corp. | New | $275K | 0.01% | 21.8% |
| 235 | RYAN | Ryan Specialty Holdings, Inc. | New | $271K | 0.01% | 12.4% |
| 236 | ASGN | Asgn Inc. | New | $271K | 0.01% | 12.5% |
| 237 | TGTX | TG Therapeutics Inc. | New | $268K | 0.01% | 28.9% |
| 238 | MMSIOther Healthcare | Merit Medical Systems Inc. | New | $267K | 0.01% | 8.2% |
| 239 | VVX | V2X, Inc. | New | $259K | 0.00% | 11.3% |
| 240 | XPO | Xpo, Inc. | New | $257K | 0.00% | 6.1% |
| 241 | GKOSOther Healthcare | Glaukos Corporation | Increased | $252K | 0.00% | 7.9% |
| 242 | LXRX | Lexicon Pharmaceuticals, Inc. | Increased | $246K | 0.00% | 10.9% |
| 243 | DVAX | Dynavax Technologies Corporation | New | $240K | 0.00% | 13.2% |
| 244 | XPOF | Xponential Fitness, Inc. | New | $239K | 0.00% | 50.2% |
| 245 | RCKT | Rocket Pharmaceuticals Inc. | New | $237K | 0.00% | 16.8% |
| 246 | KLAC | Kla Corp. | New | $232K | 0.00% | 2.1% |
| 247 | FOLD | Amicus Therapeutics Inc. | Decreased | $232K | 0.00% | 7.0% |
| 248 | DOW | Dow Inc. | New | $226K | 0.00% | 5.3% |
| 249 | UTL | Unitil Corp. | New | $225K | 0.00% | 5.0% |
| 250 | SWKS | Skyworks Solutions, Inc. | Increased | $224K | 0.00% | 29.3% |
| 251 | ONTO | Onto Innovation Inc. | Decreased | $223K | 0.00% | 7.7% |
| 252 | ADEA | Adeia Inc. | New | $217K | 0.00% | 12.0% |
| 253 | RGENOther Healthcare | Repligen Corporation | Decreased | $211K | 0.00% | 13.5% |
| 254 | ARDX | Ardelyx Inc. | New | $209K | 0.00% | 10.9% |
| 255 | FLYW | Flywire Corp. | New | $197K | 0.00% | 10.5% |
| 256 | WT | WisdomTree, Inc. | New | $194K | 0.00% | 17.6% |
| 257 | PATH | UiPath, Inc. | New | $171K | 0.00% | 26.8% |
| 258 | APLD | Applied Digital Corp. | Increased | $171K | 0.00% | 20.5% |
| 259 | KALV | KalVista Pharmaceuticals, Inc. | Increased | $153K | 0.00% | 14.4% |
| 260 | CHGG | Chegg, Inc. | New | $151K | 0.00% | 5.6% |
| 261 | NEO | Neogenomics Inc. | Decreased | $140K | 0.00% | 13.0% |
| 262 | ATXS | Astria Therapeutics Inc. | New | $134K | 0.00% | — |
| 263 | CTKBOther Healthcare | Cytek Biosciences, Inc. | Decreased | $97K | 0.00% | 5.1% |
| 264 | BFLYOther Healthcare | Butterfly Network, Inc. | $60K | 0.00% | 14.8% | |
| 265 | NXDR | Nextdoor Holdings, Inc. | New | $51K | 0.00% | 2.7% |
| 266 | OPKOther Healthcare | Opko Health, Inc. | Increased | $34K | 0.00% | 8.6% |
| 267 | NUVB | Nuvation Bio Inc. | Decreased | $16K | 0.00% | 27.6% |
Top Movers This Quarter
Share changes reflect active decisions. Value changes include price moves.
Frequently asked questions
What stocks did Deerfield Management own in Q3 2024?
Deerfield Management held 267 biotech stocks in their 13F portfolio in Q3 2024. Their top positions include NUVL, VTRS, OSCR, SPRY, NBIX. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Deerfield Management's portfolio worth in Q3 2024?
Deerfield Management's tracked biotech portfolio was worth $5.2B across 267 positions, with total assets under management of approximately $16B. Portfolio values are based on 13F filings with the SEC.
What did Deerfield Management buy in Q3 2024?
Deerfield Management initiated 136 new positions in Q3 2024, including INDV, BCAX, SVRA, ZBIO, RXRX and 131 more. They also increased 70 existing positions.
What did Deerfield Management sell in Q3 2024?
Deerfield Management fully exited 334 positions in Q3 2024, including RILYZ, WRB-PH, MRNA, MET-PF, MRSN and 329 more. They also trimmed 38 existing positions.
Is Deerfield Management a biotech fund?
Multi-strategy healthcare fund with one of the longest track records in the space. Deerfield invests across public equity, private equity, structured credit, and royalties in healthcare. Known for creative financing structures and deep industry relationships across pharma and biotech.
Want AI analysis, insider signals, and catalyst overlays for Deerfield Management?
View latest Deerfield Management portfolio →